Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 157 (2) , 403-412.e5
Abstract
No abstract availableKeywords
Funding Information
- Sanofi
- Fresenius Medical Care North America
- U.S. Department of Veterans Affairs
- Medtronic
- Bayer HealthCare
- Bristol-Myers Squibb
- Duke University
- Daiichi-Sankyo
- Eli Lilly and Company
- Icahn School of Medicine at Mount Sinai
- Astellas Pharma Canada
- Roche
- Amarin Corporation
- Bayer
- Janssen Pharmaceutica
- Daiichi Sankyo Europe
- GlaxoSmithKline
- Merck Sharp and Dohme United Kingdom
- Merck
- Portola Pharmaceuticals
- Novartis
- Biotronik
- Cleveland Clinic
- LEO Pharma Research Foundation
- AstraZeneca
- Boehringer Ingelheim
- Servier
- Pfizer
This publication has 22 references indexed in Scilit:
- Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010–2017Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2018
- Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trialsThe Lancet Gastroenterology & Hepatology, 2018
- The association between non‐vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta‐analysis of observational studiesBritish Journal of Clinical Pharmacology, 2016
- Aspirin Use Among Adults in the U.S.American Journal of Preventive Medicine, 2015
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014
- New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysisGastroenterology, 2013
- Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)Heart, 2011
- Clopidogrel with or without Omeprazole in Coronary Artery DiseaseNew England Journal of Medicine, 2010
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Risk of Upper Gastrointestinal Complications Among Users of Traditional NSAIDs and COXIBs in the General PopulationGastroenterology, 2007